These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 21427630)

  • 1. Ranibizumab for the treatment of exudative age-related macular degeneration associated with retinal pigment epithelial tear.
    Rouvas AA; Ladas ID; Georgalas I; Vergados I; Papakonstantinou D; Kotsolis AI
    Retina; 2011 Jun; 31(6):1083-8. PubMed ID: 21427630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal ranibizumab for exudative age-related macular degeneration with good baseline visual acuity.
    Saito M; Iida T; Kano M
    Retina; 2012 Jul; 32(7):1250-9. PubMed ID: 22446886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RETINAL PIGMENT EPITHELIAL TEAR AFTER INTRAVITREAL RANIBIZUMAB TREATMENT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Cho HJ; Kim HS; Yoo SG; Han JI; Lew YJ; Cho SW; Lee TG; Kim JW
    Retina; 2016 Oct; 36(10):1851-9. PubMed ID: 27074658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of retinal pigment epithelial tears after intravitreal ranibizumab injection for neovascular age-related macular degeneration.
    Cunningham ET; Feiner L; Chung C; Tuomi L; Ehrlich JS
    Ophthalmology; 2011 Dec; 118(12):2447-52. PubMed ID: 21872935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration.
    Dadgostar H; Ventura AA; Chung JY; Sharma S; Kaiser PK
    Ophthalmology; 2009 Sep; 116(9):1740-7. PubMed ID: 19643484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RETINAL PIGMENT EPITHELIAL TEAR AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION: Clinical Course and Long-Term Prognosis.
    Heimes B; Farecki ML; Bartels S; Barrelmann A; Gutfleisch M; Spital G; Lommatzsch A; Pauleikhoff D
    Retina; 2016 May; 36(5):868-74. PubMed ID: 26655607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-year follow-up of a pilot study of ranibizumab combined with proton beam irradiation as treatment for exudative age-related macular degeneration.
    Park SS; Daftari I; Phillips T; Morse LS
    Retina; 2012 May; 32(5):956-66. PubMed ID: 22183743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections.
    Chan CK; Abraham P; Meyer CH; Kokame GT; Kaiser PK; Rauser ME; Gross JG; Nuthi AS; Lin SG; Daher NS
    Retina; 2010 Feb; 30(2):203-11. PubMed ID: 19952998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of spectral-domain optical coherence tomography features in assessment of visual prognosis in eyes with neovascular age-related macular degeneration treated with ranibizumab.
    Mathew R; Richardson M; Sivaprasad S
    Am J Ophthalmol; 2013 Apr; 155(4):720-6, 726.e1. PubMed ID: 23317653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal ranibizumab injection for neovascular age-related macular degeneration in phakic versus pseudophakic eyes.
    Baek JS; Cho HJ; Cho SW; Kim CG; Kim JW
    Retina; 2013 Mar; 33(3):467-73. PubMed ID: 23400082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new grading system for retinal pigment epithelial tears.
    Sarraf D; Reddy S; Chiang A; Yu F; Jain A
    Retina; 2010; 30(7):1039-45. PubMed ID: 20458264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of the therapeutic response of intraretinal, subretinal, and subpigment epithelial compartments in exudative AMD during anti-VEGF therapy.
    Golbaz I; Ahlers C; Stock G; Schütze C; Schriefl S; Schlanitz F; Simader C; Prünte C; Schmidt-Erfurth UM
    Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1599-605. PubMed ID: 21051733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant improvements in near vision, reading speed, central visual field and related quality of life after ranibizumab treatment of wet age-related macular degeneration.
    Frennesson C; Nilsson UL; Peebo BB; Nilsson SE
    Acta Ophthalmol; 2010 Jun; 88(4):420-5. PubMed ID: 19678811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and therapeutic challenges.
    Hatef E; Ibrahim M; Nguyen QD; Do DV; Davis MJ; Rezaei KA; Kovach JL
    Retina; 2011 Jun; 31(6):1218-23. PubMed ID: 21386757
    [No Abstract]   [Full Text] [Related]  

  • 15. Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab.
    Bakall B; Folk JC; Boldt HC; Sohn EH; Stone EM; Russell SR; Mahajan VB
    Am J Ophthalmol; 2013 Jul; 156(1):15-22.e1. PubMed ID: 23706500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal pigment epithelium tear after intravitreal bevacizumab for exudative age-related macular degeneration.
    Spandau UH; Jonas JB
    Am J Ophthalmol; 2006 Dec; 142(6):1068-70. PubMed ID: 17157597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study.
    Rouvas A; Petrou P; Ntouraki A; Douvali M; Ladas I; Vergados I
    Retina; 2010 Jun; 30(6):893-902. PubMed ID: 20531142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of repeated anti-vascular endothelial growth factor therapy in eyes with retinal pigment epithelial tears.
    Moreira CA; Arana LA; Zago RJ
    Retina; 2013 Feb; 33(2):277-81. PubMed ID: 23023526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal ranibizumab for choroidal neovascularization with large submacular hemorrhage in age-related macular degeneration.
    Iacono P; Parodi MB; Introini U; La Spina C; Varano M; Bandello F
    Retina; 2014 Feb; 34(2):281-7. PubMed ID: 23851632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causes of unsuccessful ranibizumab treatment in exudative age-related macular degeneration in clinical settings.
    Cohen SY; Oubraham H; Uzzan J; Dubois L; Tadayoni R
    Retina; 2012 Sep; 32(8):1480-5. PubMed ID: 22258164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.